Skip to content

Effect of Elaeagnus angustifolia distilled water on impaired sexual function in women

Effect of nasal spray of Elaeagnus angustifolia distilled water on impaired sexual function in women: A randomized placebo-controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220612055148N1
Enrollment
60
Registered
2022-11-09
Start date
2021-08-07
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sexual function disorder. Sexual dysfunction not due to a substance or known physiological condition

Interventions

Intervention 1: Intervention group: The medicine spray contains Elaeagnus angustifolia aromatic water, which is prepared in the traditional way through distillation and is standardized in Razi Vaccine

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: All married women with a stable life with their husbands and regular sexual activity (not on the verge of divorce) Have a minimum literacy rate

Exclusion criteria

Exclusion criteria: Pregnancy, lactation and menopause Having any chronic disease (self-reported) Having a recognized mental illness (self-reported) Taking hormonal drugs and drugs that affect sexual desire and function (such as antidepressants, aspirin and anticoagulants) Being a multi-partner Occurrence of chaotic situations in at least the last 6 months Substance and alcohol abuse and sexual dysfunction in the spouse (premature ejaculation, erectile dysfunction) (self-reported)

Design outcomes

Primary

MeasureTime frame
FSFI questionnaire score. Timepoint: Completion of the questionnaire at the beginning and end of the intervention. Method of measurement: FSFI questionnaire.

Secondary

MeasureTime frame
Quantitative assessment of sexual satisfaction. Timepoint: Completion of the questionnaire at the beginning and end of the intervention. Method of measurement: Visual Analogue Scale.;Side effects. Timepoint: Fist visit, 6 and 10 weeks later. Method of measurement: ADR yellow page.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMeysam Shirzad

Tehran University of Medical Sciences

shirzadmd@gmail.com+98 21 8897 4535

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026